14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.97 $10.47 Wednesday, 1st May 2024 ZYME stock ended at $8.76. This is 2.10% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $8.55 to a day high of $9.00.
90 days $7.97 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
Jun 07, 2023 $8.83 $9.01 $8.70 $8.89 262 145
Jun 06, 2023 $8.97 $9.15 $8.71 $8.81 378 867
Jun 05, 2023 $8.76 $9.15 $8.59 $8.94 411 256
Jun 02, 2023 $8.50 $8.68 $8.38 $8.67 210 461
Jun 01, 2023 $8.24 $8.63 $8.10 $8.49 378 519
May 31, 2023 $8.18 $8.30 $8.06 $8.23 605 549
May 30, 2023 $8.26 $8.55 $7.98 $8.18 492 345
May 26, 2023 $8.25 $8.44 $8.20 $8.25 352 518
May 25, 2023 $8.85 $8.91 $8.33 $8.42 441 138
May 24, 2023 $9.15 $9.15 $8.80 $8.80 377 876
May 23, 2023 $9.22 $9.47 $9.10 $9.21 322 833
May 22, 2023 $9.80 $9.83 $9.10 $9.19 431 177
May 19, 2023 $9.60 $10.07 $9.60 $9.77 516 104
May 18, 2023 $9.24 $9.62 $9.22 $9.59 593 519
May 17, 2023 $9.05 $9.23 $8.56 $9.19 603 281
May 16, 2023 $9.62 $9.66 $8.83 $9.03 655 685
May 15, 2023 $9.88 $10.04 $9.79 $9.82 485 839
May 12, 2023 $9.98 $10.05 $9.75 $9.86 403 450
May 11, 2023 $9.65 $10.09 $9.55 $9.98 446 567
May 10, 2023 $10.00 $10.00 $9.52 $9.69 610 541
May 09, 2023 $9.79 $10.30 $9.34 $9.88 1 254 546
May 08, 2023 $8.70 $8.87 $8.49 $8.76 419 286
May 05, 2023 $8.53 $8.78 $8.44 $8.64 307 409
May 04, 2023 $8.40 $8.53 $8.18 $8.49 301 306
May 03, 2023 $8.21 $8.61 $8.16 $8.45 372 829
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT